| JXHB2100028 | E7090片 | tasurgratinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-23 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-22 | view |
| JXHL2100088 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100094 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100095 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100089 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2022-01-27 | view |
| JYHB2100198 | 盐酸司来吉兰片 | selegiline hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-03-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-12 | view |
| JXHL2100086 | 吡仑帕奈口服混悬液 | Perampanel | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2021-03-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-12 | view |
| JYHB2100097 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2021-01-27 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-01-26 | view |
| JYHB2100098 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2021-01-27 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-01-26 | view |
| JXHL2000351 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-12-26 | view |
| JXHL2000350 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-12-26 | view |
| JYHB2002332 | 枸橼酸托瑞米芬片 | toremifene citrate | Tablet | Chemical Drugs | Supplementary Application | 2020-11-19 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-12-01 | view |
| JYHB2002301 | 复方甘草酸苷注射液 | Glycyrrhizin;Glycine;DL-Methionine | Injection | Chemical Drugs | Supplementary Application | 2020-11-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-11-25 | view |
| JYHB2002300 | 复方甘草酸苷片 | Glycyrrhizin;Glycine;DL-Methionine | Tablet | Chemical Drugs | Supplementary Application | 2020-11-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-11-25 | view |
| JXHL2000301 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-11-12 | view |
| JXHL2000300 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-05-09 | view |
| JXHL2000299 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-11-12 | view |
| JYHB2002287 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-11-11 | view |
| JYHB2002210 | 盐酸司来吉兰片 | selegiline hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-11-04 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-11-17 | view |
| JYHB2002202 | 酒石酸西尼必利片 | cinitapride tartrate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-11-02 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-11-17 | view |
